Evofem’s David Friend Appointed Daré Bio Chief Scientific Officer

David Friend has been appointed chief scientific officer of San Diego-based Daré Biosciences (NASDAQ: [[ticker:DARE]]). Friend comes to Daré from another San Diego biotech company, Evofem Biosciences (NASDAQ: [[ticker:EVFM]]), where he was chief scientific officer. Daré develops treatments focusing on women’s reproductive health. The company gained its public stock listing last year through a reverse merger with cancer drug developer Cerulean Pharma. Daré’s lead product candidate is Ovaprene, a contraceptive ring that has advanced into clinical testing.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan